Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 29 (RNA5SP29) is a non-coding RNA classified as an rRNA pseudogene, specifically a non-functional genomic copy similar to the gene encoding 5S ribosomal RNA[2][4][7]. Unlike functional 5S rRNA genes, which encode a highly conserved component of the large ribosomal subunit essential for protein synthesis[1][3][5], pseudogenes like RNA5SP29 are genetic relics and are not transcribed into functional RNA molecules[4][7]. These arise from gene duplication events but have since accumulated mutations or deletions, losing their coding potential and regulatory sequences required for proper expression[7]. While pseudogenes are not conventional therapeutic targets, some recent research suggests differential pseudogene expression may serve as biomarkers in cancer and might participate in gene regulation through mechanisms such as acting as competitive endogenous RNAs or miRNA decoys[6]. However, there are no currently validated disease mechanisms, drugs, or therapies that specifically target RNA5SP29.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 29 (RNA5SP29).